Attilizumab and targeting and immune checkpoint inhibitor combination after TACE in the treatment of patients with advanced primary liver cancer

Zhang Xiaozhao, Lei Kai, Qi Yabin, et al

Journal of Practical Hepatology . 2025, (5): 759 -762 . DOI: 10.3969/j.issn.1672-5069.2025.05.030